Post date April 23, 2024 Experience Korro Bio $70 million private placement The PIPE consists of common stock
Post date April 23, 2024 Experience TScan Therapeutics $150 million stock and pre-funded warrants offering The stock is listed on the Nasdaq Global Market
Post date April 22, 2024 Experience Intra-Cellular Therapies $500 million stock offering The shares are listed on the Nasdaq Global Select Market
Post date April 16, 2024 Experience Nurix Therapeutics $175 million stock and pre-funded warrants offering The stock is listed on the Nasdaq Global Market
Post date April 10, 2024 Experience Biodesix $55 million follow-on offering The common stock is listed on the Nasdaq Global Market
Post date April 4, 2024 Experience Adagene $100 million at-the-market offering We advised Adagene on the offering
Post date April 2, 2024 Experience Stoke Therapeutics $125 million stock and pre-funded warrants offering The common stock is listed on the Nasdaq Global Select Market
Post date March 25, 2024 Experience Galderma Group CHF2.3 billion ($2.6 billion) IPO We advised Galderma on its IPO
Post date March 22, 2024 Experience Auna $360 million U.S. IPO We advised Auna on its U.S. IPO and NYSE listing
Post date March 21, 2024 Experience Haleon $3.1 billion secondary offering The shares are listed on the NYSE